In 2005, my first book, ‘FOWL! Bird Flu – It’s Not What You Think, was written in ‘real time’ as the entire fiasco was unfolding. Given what we’ve been through the last three years – i.e. what the WEF, WHO, UN, a long list of three-letter agencies, and our own power-wielding government seemingly have gotten away with – a review of what happened during the Bird flu in 2005 will give an important backdrop for current plans that are steam-rolling forward.
You may be more than a little surprised that this information came from 2004 because it reads as though it came from today’s newspaper. The text has been only slightly reformatted for clarity. This substack is a little longer than usual, but it is important. Pour yourself a beverage, sit back, take a deep breath, and dive in.
PS. For a much more detailed timeline of how the public health service became a weapon form against us, read this incredibly detailed substack by Kathrine Watt. This document is incredible work. (Thank you, Katherine!)
Historically, vaccination laws in the U.S. are passed and monitored at the state level, not mandated or enforced at the federal level. While the groundwork to change all that actually began in the 1940s, onJanuary 28, 2003, during President George W. Bush’s State of the Union address, the creation of Project BioShield was revealed. This new legislation was a comprehensive effort to develop and make available “modern, effective drugs and vaccines to protect against possible attacks by biological and chemical weapons.” The initial stage of the program was estimated to cost $5.6 billion over ten years.
Project BioShield established three major components:
- The creation of a permanent, ‘indefinite funding authority’ to spur the development of medical countermeasures that enabled the government to purchase vaccines and other therapies as soon as experts believed that they could pass the mantra ‘safe and effective.’ Note: The vaccines were not going to be approved for use after extensive study and testing; they could be put to use with a wink, a wet thumb to the air, and a nod that they were good to go.
- Grant new authority to the NIH [think NIAID – Fauci]to speed research and development of drugs and vaccines to counter bioterrorism threats and,
- Develop ‘fast track’ provisions such as the declaration of emergency use authorizations [EUA] for the release of treatments, drugs, and vaccines that were still under FDA consideration. [REF: Office of the Press Secretary. “President Details Project BioShield,” The White House, 3 February 2003.}
As sweeping as the provisions were at the time, the legislation failed to include the key provisions sought by the drug companies—complete liability protection for all bioterrorism products.
Throughout 2003, 2004, and 2005, many bills were introduced by both the House and the Senate; in fact, 13 bills were introduced in 2005 alone to achieve this desired goal. But it wasn’t until October 17, 2005, whenThe Biodefense and Pandemic Vaccine and Drug Development Act of 2005 (known as BioShield II)was put on the front burner to ‘make good’ on the promise of protection to drug makers.
Introduced by senators Bill Frist (R-TN) and Richard Burr (R-NC), the bill was accelerated through the Senate Health, Education, Labor, and Pensions (HELP) Committee, without hearings. According to Burr’s news release, its purpose was to create a partnership between the government and private corporations by ‘rapidly releasing effective medical drugs and vaccines to protect the United States from deliberate, accidental, and natural incidents involving biological pathogens.’
This legislation was designed to give unprecedented advantages to the industry and would remove or severely weaken all safeguards that had long been in place to prevent dangerous or unapproved vaccines, drugs, and medical devices from reaching consumers. The bill also introduced the creation of a new agency within HHS, the Biomedical Advanced Research and Development Agency (BARDA), which would be given the responsibility for handling the $5.6B initiative.
BARDA was officially created in 2006 as part of the Pandemic and All Hazards Preparedness Act (PAHPA). To this day, BARDA manages and funds the research, development, and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks. For FY2023, BARDA’s budget is $7.345B, a13% increase over FY2022.
Public outrage against BioShield II began almost immediately. Patriot websites, conservative news outlets, and nationwide talk radio hosts began to decry the unbelievable benefits that the passage of S. 1873 would convey to drug companies. Dozens of activist groups representing thousands of constituents rallied and mounted campaigns to notify Congress of their dissatisfaction with the bill. Faxes, emails, and phone calls to congressional offices conveyed message after angry message, opposing the carte blanche promises about to be handed to the drug makers. Because the outcry against S.1873 was so strong, the possibility of its passage…
Continue reading full story: Key Laws You Need to Know